ACADIA Pharmaceuticals Inc
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 88.6 | 19.9 | 13.5 | 12.2 | 16.4 | 13.9 | 11.7 | 10.3 | 11.5 | |
| 693.7 | 201.4 | 128.3 | 54.1 | 49.5 | 29.9 | 17.7 | 10.3 | 12.5 | 9.5 | 16.3 | 14.6 | 17.5 | 19.5 | 17.9 | 19.3 | 15.6 | 19.3 | 9.0 | 8.4 | 5.6 | 7.7 | 7.9 | 4.4 | 5.2 | 5.0 | 5.9 | 7.2 | 5.4 | 7.2 | 3.8 | 3.0 | 2.8 | 3.2 | 2.8 | 3.6 | 3.5 | 4.3 | 3.5 | 3.8 | |
| 6.5 | 6.7 | 9.1 | 8.2 | 12.2 | 11.1 | 9.2 | 7.2 | 11.6 | 4.5 | 9.3 | 9.9 | 7.6 | 9.5 | 10.3 | 11.5 | 10.0 | 13.6 | 7.1 | 6.9 | 4.7 | 6.9 | 8.8 | 5.2 | 6.2 | 6.4 | 8.2 | 10.0 | 9.4 | 12.1 | 6.6 | 5.2 | 4.4 | 4.2 | 3.6 | 4.4 | 4.0 | 3.7 | 3.1 | 3.3 | |
| 665.2 | 192.0 | 123.5 | 51.8 | 48.3 | 29.4 | 17.0 | 9.9 | 12.2 | – | 15.9 | 14.3 | 16.2 | 19.0 | 17.5 | 18.5 | 14.5 | 18.6 | 8.4 | 7.9 | 5.4 | 7.5 | 7.5 | 4.2 | 4.9 | 4.8 | 5.3 | 7.0 | 5.3 | 6.9 | 3.5 | 2.9 | 2.6 | 2.9 | 2.6 | 3.3 | 3.2 | 4.1 | 3.3 | 3.5 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 113.0 | 44.4 | 16.2 | 23.0 | 20.8 | 26.7 | 25.4 | 29.3 | 28.2 | 34.5 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 313.0 | 48.4 | 33.7 | 12.6 | 19.5 | 56.1 | 19.5 | 18.4 | 43.5 | 18.1 | 25.1 | |
| -5.1% | -6.3% | -6.0% | -7.1% | -5.5% | -5.9% | -6.9% | -9.2% | -6.1% | -8.0% | -4.9% | -4.8% | -3.1% | -2.3% | -2.1% | -1.8% | -2.2% | -1.7% | -3.8% | -3.6% | -5.0% | -3.4% | -3.6% | -5.7% | -4.3% | -4.4% | -1.8% | -0.9% | -2.7% | 0.3% | 2.1% | 3.0% | 7.9% | 5.1% | 1.8% | 5.1% | 5.4% | 2.3% | 5.5% | 4.0% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| -788.1% | -56.8% | 77.5% | 84.5% | 87.5% | 89.5% | 91.4% | 91.6% | 91.5% | 91.8% | 91.8% | 92.7% | 93.8% | 94.2% | 94.5% | 94.8% | 95.1% | 95.3% | 95.6% | 95.7% | 95.4% | 96.0% | 96.5% | 97.1% | 98.0% | 98.0% | 98.3% | 97.5% | 95.9% | 94.3% | 92.3% | 91.7% | 91.6% | 91.5% | 92.0% | 92.0% | 91.9% | 91.7% | 91.5% | 91.1% | |
| -4,458.8% | -1,574.1% | -954.7% | -488.8% | -323.4% | -235.0% | -163.8% | -137.9% | -120.4% | -110.6% | -117.8% | -103.5% | -85.7% | -72.7% | -67.8% | -59.9% | -65.8% | -64.9% | -57.6% | -56.9% | -40.7% | -35.2% | -43.9% | -40.3% | -43.4% | -43.2% | -31.6% | -23.1% | -24.4% | -10.1% | -0.6% | 2.6% | 12.1% | 24.1% | 23.6% | 23.2% | 23.0% | 9.8% | 7.4% | 7.6% | |
| -4,427.8% | -1,565.9% | -948.9% | -485.1% | -320.7% | -231.7% | -161.4% | -136.0% | -119.6% | -109.6% | -116.1% | -101.5% | -82.5% | -69.4% | -65.0% | -57.3% | -63.9% | -63.7% | -56.7% | -56.5% | -40.4% | -34.7% | -43.5% | -39.9% | -42.5% | -41.8% | -28.1% | -20.1% | -23.5% | -8.4% | -0.2% | 3.4% | 13.8% | 23.6% | 23.0% | 21.8% | 24.9% | 36.5% | 34.3% | 33.4% | |
| -3,555.3% | -1,268.9% | -765.5% | -386.5% | -270.3% | -175.1% | -121.9% | -94.6% | -76.9% | -75.8% | -79.4% | -70.6% | -53.9% | -44.9% | -37.5% | -35.3% | -34.4% | -32.5% | -33.8% | -30.3% | -28.1% | -26.2% | -28.8% | -25.3% | -22.2% | -22.0% | -10.7% | -6.2% | -14.7% | 2.3% | 7.8% | 9.0% | 21.8% | 16.4% | 5.0% | 18.4% | 18.9% | 9.8% | 19.4% | 15.3% | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| -41.3% | -52.4% | -67.6% | -73.6% | -79.3% | -86.3% | -84.1% | -95.1% | -111.2% | -51.2% | -66.0% | -68.9% | -35.9% | -33.7% | -37.3% | -34.0% | -40.9% | -44.9% | -44.7% | -46.3% | -33.8% | -31.0% | -48.2% | -47.1% | -51.1% | -53.9% | -39.0% | -28.0% | -41.1% | -14.2% | -0.4% | 5.9% | 22.3% | 30.9% | 29.9% | 27.0% | 28.5% | 31.9% | 30.1% | 29.1% | |
| -38.6% | -48.4% | -61.5% | -67.0% | -72.3% | -75.3% | -72.9% | -79.9% | -93.3% | -45.4% | -55.1% | -58.1% | -32.4% | -30.0% | -31.8% | -29.6% | -33.7% | -36.0% | -34.4% | -36.1% | -26.7% | -24.0% | -34.4% | -33.4% | -36.1% | -36.7% | -22.3% | -17.2% | -23.5% | -8.2% | -0.2% | 3.3% | 13.2% | 19.1% | 20.2% | 18.1% | 19.6% | 25.0% | 23.4% | 21.8% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| -154 | -164 | -157 | -144 | -113 | -69 | -116 | -74 | -64 | – | -86 | -70 | -382 | -186 | -170 | -308 | -448 | -321 | -298 | -259 | -86 | -139 | -196 | -131 | -146 | -106 | -282 | -99 | -89 | -179 | -194 | -167 | -146 | -310 | -206 | -242 | -246 | -166 | -270 | -371 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -7.6 | -2.9 | -1.0 | -2.6 | -1.7 | -1.9 | -1.8 | -1.1 | -2.1 | -3.2 | |
| 93.6% | 92.4% | 91.0% | 91.0% | 91.2% | 87.2% | 86.6% | 84.0% | 83.9% | 88.7% | 83.5% | 84.4% | 90.0% | 89.3% | 85.4% | 87.3% | 82.3% | 80.1% | 77.0% | 78.0% | 79.0% | 77.3% | 71.3% | 71.0% | 70.7% | 68.1% | 57.1% | 61.6% | 57.3% | 57.6% | 54.3% | 56.5% | 59.1% | 61.7% | 67.6% | 67.1% | 68.9% | 78.5% | 77.7% | 75.0% | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| -2.03 | -2.24 | -2.54 | -2.50 | -2.44 | -2.33 | -2.05 | -2.01 | -1.99 | -1.86 | -1.92 | -1.86 | -1.70 | -1.52 | -1.53 | -1.44 | -1.69 | -1.77 | -1.62 | -1.63 | -1.19 | -1.04 | -1.33 | -1.27 | -1.34 | -1.33 | -0.90 | -0.67 | -0.91 | -0.37 | -0.01 | 0.18 | 0.77 | 1.36 | 1.37 | 1.32 | 1.53 | 2.28 | 2.18 | 2.20 | |
| 0.05 | 0.14 | 0.27 | 0.52 | 0.76 | 1.01 | 1.27 | 1.48 | 1.66 | 1.70 | 1.65 | 1.83 | 2.06 | 2.19 | 2.36 | 2.51 | 2.65 | 2.77 | 2.86 | 2.89 | 2.95 | 3.01 | 3.06 | 3.17 | 3.16 | 3.19 | 3.21 | 3.34 | 3.85 | 4.36 | 4.88 | 5.36 | 5.59 | 5.76 | 5.94 | 6.04 | 6.14 | 6.25 | 6.34 | 6.59 | |
| 4.92 | 4.28 | 3.76 | 3.40 | 3.08 | 2.70 | 2.44 | 2.12 | 1.79 | 3.64 | 2.91 | 2.69 | 4.72 | 4.53 | 4.11 | 4.24 | 4.14 | 3.94 | 3.63 | 3.52 | 3.53 | 3.36 | 2.76 | 2.69 | 2.63 | 2.47 | 2.31 | 2.40 | 2.21 | 2.59 | 2.78 | 3.11 | 3.47 | 4.40 | 4.56 | 4.88 | 5.38 | 7.16 | 7.23 | 7.56 | |
| -1.63 | -1.81 | -2.05 | -1.99 | -2.06 | -1.76 | -1.55 | -1.40 | -1.28 | -1.29 | -1.31 | -1.29 | -1.11 | -0.99 | -0.88 | -0.89 | -0.91 | -0.90 | -0.97 | -0.88 | -0.83 | -0.79 | -0.88 | -0.80 | -0.70 | -0.70 | -0.34 | -0.21 | -0.56 | 0.10 | 0.38 | 0.48 | 1.22 | 0.94 | 0.30 | 1.11 | 1.16 | 0.61 | 1.23 | 1.01 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.